Home › Funds › a16z Capital Management, L.L.C. › DMRA

a16z Capital Management, L.L.C. position in DMRA

DAMORA THERAPEUTICS INC COM SHS · Health Care

a16z Capital Management, L.L.C. reported holding 1,236,157 shares of DMRA (DAMORA THERAPEUTICS INC COM SHS) in its Q2 2026 13F filing — a position valued at US$32.2M, representing 0.23% of its reported portfolio and ranking #10 among its reported holdings. a16z Capital Management, L.L.C. has disclosed DMRA holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

Latest position (Q2 2026)1.24M sh
Reported value held$32.15M
Portfolio Weight0.23%
First reportedQ1 2026
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How a16z Capital Management, L.L.C.'s DMRA position evolved

a16z Capital Management, L.L.C. first disclosed a stake in DMRA in Q1 2026 at 1,236,157 shares (US$32.0M). The position peaked in Q2 2026 at 1,236,157 shares, worth US$32.2M. Across 2 filings, a16z Capital Management, L.L.C. held the position steady without any share-count change. The most recent filing (Q2 2026) shows 1,236,157 shares valued at US$32.2M.

Quarter by quarter

QuarterSharesValueChange
Q1 2026 1.24M $32.02M New
Q2 2026 1.24M $32.15M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About DMRA and 13F data

DMRA (DAMORA THERAPEUTICS INC COM SHS) is a Health Care company. 105 other funds we track also report a position in DMRA — the largest reported positions include Fairmount Funds Management LLC (US$226.6M), Avoro Capital Advisors LLC (US$98.4M), Venrock Adviser, LLC (US$93.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding DMRA

All DMRA fund holders →

FAQ

How long has a16z Capital Management, L.L.C. held DMRA?

a16z Capital Management, L.L.C. has disclosed DMRA holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

What is a16z Capital Management, L.L.C.'s current position in DMRA?

As of Q2 2026, a16z Capital Management, L.L.C. holds 1.24M shares of DMRA (DAMORA THERAPEUTICS INC COM SHS), valued at $32.15M, representing 0.23% of its reported portfolio and ranking #10.

Has a16z Capital Management, L.L.C. been buying or selling DMRA?

In the latest 13F filing (Q2 2026), a16z Capital Management, L.L.C. held unchanged its position in DMRA. The position peaked in Q2 2026 at 1.24M shares.

Which other funds hold DMRA?

Other major institutional holders of DMRA include Fairmount Funds Management LLC, Avoro Capital Advisors LLC, Venrock Adviser, LLC, among 105 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.